Items where Author is "Ho, G. F."

Article

Tan, Ting Ting and Tan, Maw Pin and Lam, Chee Loong and Loh, Ee Chin and David Paul, Capelle and Sheriza Izwa, Zainuddin and Ang, Bin-Ting and Lim, Min Ai and Lai, Natalie Zi and Tung, Yu-Zhen and Yee, Hway Ann and Ng, Chong Guan and Ho, G. F. and See, Mee Hoong and Teh, Mei Sze and Lai, Lee Lee and 5 Ranjit Kaur, Pritam Singh and Chai, Chee Shee and Ng, Diana Leh-Ching and Tan, Seng Beng (2021) Mindful gratitude journaling: psychological distress, quality of life and suffering in advanced cancer: a randomised controlled trial. BMJ Supportive & Palliative Care (2021). pp. 1-8. ISSN ISSN 2045-4368

Chai, Chee Shee and Liam, Chong Kin and Lin, O. Po and Pang, Yong Kek and Ho, G. F. and Alip, A. and Wong, C. K. and Poh, M. E. (2019) Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma. Annals of oncology, 30 (9). p. 164. ISSN 0923-7534

Chai, Chee Shee and Lin, O. Po and Liam, Chong Kin and Pang, Yong Kek and Ho, G. F. and Alip, A. and Wong, Chee Kuan and Poh, Mau Ern and Tan, Jiunn Liang (2019) Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib. Annals of oncology, 30 (9). p. 167. ISSN 0923-7534

Chai, Chee Shee and Liam, Chong Kin and Poh, Mau Ern and Ong, D. B. L. and Cheah, P. L. and Pang, Yong Kek and Ho, G. F. and Alip, A. (2019) Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology, 14 (10). S1038. ISSN 1556-0864